Series 2 Episode 8 - Navigating a genetic diagnosis
What might it be like to navigate a genetic diagnosis and share it with family members? We talk to Julie Young from the CanGene CanVar patient reference panel about her experience.
On this page
Series 2 Episode 7 - Why research regulation falls short in genomic medicine
enMay 02, 2023
About this Episode
As a society, we tend to focus a lot on risk and try to control it through regulation - but how well does that work for ensuring ethical practice in genomics? We talk to Dr Kate Lyle about her research on this topic.
Recent Episodes from Centre for Personalised Medicine
Series 2 Episode 7 - Why research regulation falls short in genomic medicine
As a society, we tend to focus a lot on risk and try to control it through regulation - but how well does that work for ensuring ethical practice in genomics? We talk to Dr Kate Lyle about her research on this topic.
Series 2 Episode 6 - Diversifying genomics
What are the ethical challenges with diversifying genomic data? We talk to Faranak Hardcastle about her work exploring this.
Series 2 Episode 5 - Who's 'the patient' in genomic medicine?
We live our lives alongside others, and our decisions have consequences for those close to us - what does this mean for how we define 'the patient' in genomic medicine? Susie Weller talks to us about this issue.
Series 2 Episode 4 - Newborn genome screening
What sort of findings might we get from newborn genome screening? What might this mean for the NHS? Rachel Horton talks to Gabby Samuel and Lisa Ballard.
Series 2 Episode 3 - Sharing genetic results within families
Who does a genetic result belong to? What might help people to share genetic information with their relatives? We talk to Lisa Ballard and Anneke Lucassen.
Series 2 Episode 2 - Why context matters in genetic testing
How can the same genetic finding can mean different things in different people? What does this mean for 'personalising' genetic results? Anneke Lucassen talks to us about this issue.
Series 2 Episode 1 - The environmental cost of personalised medicine
How does personalised medicine impact on the environment? What does this mean for how we should collect and store data? Gabrielle Samuel talks to us about these issues. A transcript of this episode is available at https://media.podcasts.ox.ac.uk/medsci/cpm/2022-06-15-medsci-cpm-s2-ep-1.pdf
Series 1 Episode 2 - Meet the Advisory Board: Dame Mary Archer
In the second episode of the Meet the Advisory Board Series we talked to Dame Mary Archer about personalised medicine in practice, her academic career and her plethora of other roles she has held and is holding at the moment. This interview was created by the Centre for Personalised Medicine (CPM), a partnership between University of Oxford’s Wellcome Centre for Human Genetics (WHG) and St Anne’s College, Oxford. The CPM provides opportunities for students, academics, clinicians and the public to explore the benefits and challenges of Personalised Medicine.
Visit our website: [http://www.cpm.well.ox.ac.uk
Series 1 Episode 1 - Meet the Advisory Board: Dr Magdalena Skipper
In the first episode of the Meet the Advisory Board Series we talked to Dr Magdalena Skipper to find out about her remarkable career in academia, science publishing and her views on personalised medicine. This interview was created by the Centre for Personalised Medicine (CPM), a partnership between University of Oxford’s Wellcome Centre for Human Genetics (WHG) and St Anne’s College, Oxford. The CPM provides opportunities for students, academics, clinicians and the public to explore the benefits and challenges of Personalised Medicine.
Visit our website: http://www.cpm.well.ox.ac.uk for a transcript of the episode, more information and upcoming events, and follow us @CPMOxford